13 completed. 6 Phase 3, 4 Phase 2, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Deoxycholic Acid Injection: new trials by email Literature Review of Deoxycholic Acid Injection trials Research Report on Deoxycholic Acid Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat Deoxycholic Acid Injection - Flank Fat | Not applicable | Completed | Espad Pharmed | 30 | 2024-08-01 | 2026-01-21 |
| Patient Experience Study of Deoxycholic Acid Injection Deoxycholic Acid Injection, Placebo, Cold Compress - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 84 | 2013-12-01 | 2015-07-28 |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 516 | 2012-03-01 | 2015-06-15 |
| Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection) Deoxycholic acid Injection, Placebo - Subcutaneous Fat | Completed | Allergan | 201 | 2012-02-14 | 2018-09-24 | |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 506 | 2012-02-01 | 2015-06-15 |
| Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 165 | 2011-08-01 | 2016-01-14 |
| Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 360 | 2011-01-01 | 2015-06-12 |
| Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 363 | 2010-12-01 | 2015-07-14 |
| Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 2 | Completed | Kythera Biopharmaceuticals | 129 | 2009-12-01 | 2015-06-15 |
| Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Deoxycholic Acid Injection, Placebo - Moderate or Severe Submental Fullness | Phase 2 | Completed | Kythera Biopharmaceuticals | 73 | 2008-04-01 | 2015-07-14 |
| Phase 2 Study for the Treatment of Superficial Lipomas Deoxycholic Acid Injection, Placebo - Lipoma | Phase 2 | Completed | Kythera Biopharmaceuticals | 62 | 2007-11-01 | 2016-01-14 |
| Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Deoxycholic Acid Injection, Placebo - Moderate or Severe Submental Fullness | Phase 1 / Phase 2 | Completed | Kythera Biopharmaceuticals | 85 | 2007-08-01 | 2015-07-14 |
| Deoxycholic Acid Injection for the Treatment of Superficial Lipomas Deoxycholic Acid Injection, Placebo - Lipoma | Phase 1 | Completed | Kythera Biopharmaceuticals | 16 | 2007-01-01 | 2015-12-10 |
Lymphoma, Follicular (9) · Lipoma (2)
Kythera Biopharmaceuticals (11) · Allergan (1) · Espad Pharmed (1)
United States (7) · Canada (4) · United Kingdom (4) · Germany (3) · Australia (2) · Belgium (2) · France (2) · Spain (2) · Iran (1) · Italy (1)
Frederick Beddingfield, MD, PhD (5) · Beta Bowen (1) · Frederick Beddingfield, III, M.D., Ph.D. (1) · Frederick Beddingfield, III, M.D., PhD (1) · Frederick Beddingfield, III, MD, PhD (1) · Frederick Beddingfield, MD. PhD (1) · Patricia S. Walker, M.D., Ph.D. (1) · Stacy R. Smith, M.D. (1)